NEXGEL Inc (NXGL): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand NEXGEL, Inc (NXGL)

P/S levels on the chart demonstrate the market valuation of NEXGEL, Inc., where the 0.20 indicator determines the metric's magnitude. NEXGEL, Inc. produces high-margin medical gels, the expansion of which is limited by production capacities. Patented dressings for clinics ensure stable demand, creating procurement inertia. Meanwhile, moderate pricing power within the niche is constrained by the influence of major suppliers.

Price-to-Revenue Ratio: NEXGEL (NXGL) for 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for NEXGEL, Inc (NXGL)

- stock quotes and analyst forecast:
Price nexgel.com|NXGL - Price Target Chart
- stock exchange capitalization data:
Market Value NEXGEL, Inc|NXGL - Real Price to Acquire Entire Company
- book capitalization indicators:
Book Value per Share NEXGEL|NXGL - Company Book Value|Market Cap to Net Assets Ratio nexgel.com|NXGL - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital NEXGEL, Inc.|NXGL - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio NEXGEL Inc|NXGL - Company Total Debt|Debt to Book Capital NEXGEL, Inc|NXGL - Company Long-Term Debt|Short-Term Debt Volume NEXGEL|Immediate Liquidity Ratio nexgel.com
- company profitability and valuation multiples indicators:
NXGL - Net Profit|Expected Net Profit NEXGEL, Inc.|NXGL - Price to Earnings Ratio|Price to Future Earnings Ratio NEXGEL Inc.|NXGL - PEG Multiple|Enterprise Value to EBITDA Multiple NEXGEL, Inc|NXGL - Operating profit EBITDA|Net earnings per one share for the last twelve months NEXGEL|NXGL - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months nexgel.com|NXGL - Net earnings per share growth this year|Expected earnings per share trend next year NEXGEL, Inc.
- total revenue and sales volume data:
NXGL - Revenue and Sales Volume|Company Future Sales nexgel.com|NXGL - Price-to-Revenue Ratio|Market Cap to Projected Revenue NEXGEL, Inc
Summary company analytics:nexgel.com
Mass-produced product of nexgel.com

The P/S ratio determines the market value of one dollar of revenue, allowing for an assessment of the premium paid for a business regardless of current earnings. For NEXGEL, Inc. (NXGL), this metric reflects market expectations regarding the scaling of automated production for hydrogel patches. By analyzing the ratio of share price to sales volume, an investor can see how cost reductions during production scale-ups impact capitalization. A rational balance of this metric confirms the company's investment attractiveness.

Competitors of NEXGEL, Inc.

Market Cap to Sales Volume ISRG|Price-to-Revenue Ratio Danaher DHR|Market Capitalization-to-Revenue Ratio BDX|STE: Market Cap to Revenue|WST - P/S Multiple|Baxter International (BAX) - Price-to-Revenue Ratio|Market Cap to Revenue masimo.com|STVN (Stevanato Group) - P/S Multiple|Price to Sales Teleflex Inc. TFX|Price-to-Revenue Ratio Merit Medical Systems Inc (MMSI)|Nobel Biocare - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (dentsplysirona.com)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Inc ATRC|STAAR Surgical Corp (STAA) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio NAGE|ZIMV (ZimVie Inc.) - P/S Multiple|Price to Sales angiodynamics.com ANGO|Market Cap to Revenue CERS (Cerus)|Alpha Teknova - Market Cap to Revenue Ratio|P/S Multiple MGRM (Monogram Technologies Inc)|Price-to-Revenue Multiple Sharps Technology Inc|InfuSystem Inc - P/S Multiple|Price to Sales utahmed.com|korumedical.com (KRMD) - Price-to-Revenue Ratio|NYXH (Nyxoah SA) - Price-to-Revenue Ratio|Market Cap to Revenue MBOT|PDEX: Market Capitalization-to-Revenue Ratio|P/S Multiple ZTEK|Price-to-Revenue Coefficient elutia.com|Price-to-Revenue Ratio Milestone Scientific Inc. MLSS|RVP: Market Cap to Revenue Ratio|Harvard Bioscience - P/S Multiple|Femasys Corporation (FEMY) - Market Cap to Revenue|MHUA (meihuamed.com) - Market Cap to Revenue|POAI - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Callan JMB Inc.|Market Cap to Revenue Ratio ATRI (Atrion Corp.)|Market Cap to Revenue NURO (NeuroMetrix Corp)